期刊文献+

AxSYM和Architect i1000 sr系统测定地高辛血药浓度的比较 被引量:3

Comparison of Ax SYM and Architect i1000 sr system for determination of digoxin concentration
下载PDF
导出
摘要 目的:研究Ax SYM和Architect i1000 sr系统测定地高辛血药浓度结果相关性,并比较其对内源性地高辛样免疫活性物质的敏感性。方法:同时采用Ax SYM和Architect i1000 sr系统测定100例患者的地高辛血药浓度,以Ax SYM的测定值为X,Architect i1000 sr的测定值为Y,进行线性回归,评价其相关性。同时采用两个系统测定56例未服用地高辛患者的表观地高辛血药浓度,比较其对内源性地高辛样免疫活性物质的敏感性。结果:Architect i1000 sr的测定值小于Ax SYM的测定值,两者相关性良好(r=0.931),回归方程为Y=0.746 X–0.315 8。56例未服用地高辛患者Architect i1000 sr测得的表观地高辛浓度均为0,Ax SYM测定时28例患者表观地高辛浓度大于0.3 ng·m L-1。结论:尽管Ax SYM和Architect i1000 sr系统测定地高辛血药浓度结果相关性良好,然而Architect i1000 sr系统的测定值偏低,进行方法间切换时,药师和医师应予以注意。Architect i1000 sr系统对内源性地高辛样免疫活性物质的敏感性低于Ax SYM系统。 Objective: To assess the correlation between the serum digoxin levels measured by AxSYM and Architect il000 sr systems and compare the two systems with respect to interference from digoxin-like immunoreactive substances. Methods: Serum digoxin levels of 100 patients were determined by AxSYM and Architect i1000 sr systems. Regression analysis was performed to evaluate the correlation. The interference of digoxin-like immunoreactive substances on both assays was investigated in samples from 56 patients who were not taking digoxin. Results: Serum digoxin levels determined by Architect il000 sr system were significantly lower than those of AxSYM system. Concordance analysis revealed a positive and statistically significant correlation coefficient (r = 0.931). The equation was Y = 0.746 X- 0.315 8. The apparent digoxin concentrations were 0 in all of the non digoxin-treated patients when measured with Architect i1000 sr system, while the apparent digoxin concentrations of 28 non digoxin-treated patients were greater than 0.3 ng.mL-1 when measured with AxSYM system. Conclusion: The correlation between the serum digoxin levels from both assays is well. However, values obtained by Architect il000 sr system are lower than those of AxSYM system. Susceptibility to interference from digoxin-like immunoreactive substances of AxSYM system was significantly greater than that of Architect i1000 sr system.
出处 《中国药物应用与监测》 CAS 2015年第4期212-214,共3页 Chinese Journal of Drug Application and Monitoring
关键词 地高辛 血药浓度 AX SYM ARCHITECT i1000 SR Digoxin Blood drug concentration AxSYM Architect i1000 sr
  • 相关文献

参考文献7

  • 1Jones TE, Morris RG. Discordant results from "real-world" patient samples assayed for digoxin[J]. Ann Phannacother, 2008, 42(12): 1797-1803.
  • 2Hermida-Cadahia EF, Calvo MM, Tutor JC. Interference of circulating endogenous antibodies on the Dimension DGNA digoxin immunoassay: elimination with a heterophilic blocking reagent[J]. Clin Biochem, 2010, 43(18): 1475-1477.
  • 3Ma J, Esplin MS, Adair CD, et al. Increasing evidence for and regulation of a human placental endogenous digitalis-like factor[J]. Reprod Sci, 2012, 19(4): 437-448.
  • 4DeFrance A, Armbruster D, Petty D, et al. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spirolactone, potassium canrenoate, and their common metabolite canrenone[J]. Ther Drug Monit, 2011, 33(1): 128-131.
  • 5Albert Vicent E, Ferriols Lisart R, Roch Ventura MA, et al. Comparing the digoxin test with the architect i1000sr system with respect to the AxSYM system[J]. Farm Hosp, 2011, 35(5): 256-259.
  • 6李金恒,吴振国,许劲秋,周燕,储小曼.老年心功能不全患者血清地高辛样免疫活性物质测定[J].药学学报,1998,33(9):655-658. 被引量:6
  • 7Lampon N, Pampin F, Tutor JC. Investigation of possible interference by digoxin-like immunoreactive substances on the Architect iDigoxin CMIA in serum samples from pregnant women, and patients with liver disease, renal insufficiency, critical illness, and kidney and liver transplant[J]. Clin Lab, 2012, 58(11-12): 1301-1304.

二级参考文献4

  • 1李金恒,药学学报,1997年,32卷,174页
  • 2Li J H,中国药理学报,1995年,16卷,47页
  • 3李金恒,中国药理学通报,1995年,1卷,256页
  • 4Jolley M E,Clin Chem,1981年,27卷,1190页

共引文献5

同被引文献22

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部